A Method of Modulating Cellular Activity

Details for Australian Patent Application No. 2003204254 (hide)

Owner Johnson & Johnson Pharmaceutical Research and Development LLC

Inventors Xia, Pu; Wattenberg, Brian; Vadas, Mathew; Barter, Philip; Pitson, Stuart; Rye, Kerry-Anne; Gamble, Jennifer

Agent Blake Dawson Waldron

Pub. Number AU-B-2003204254

Parent 89658

Filing date 19 May 2003

Wipo publication date 19 June 2003

Acceptance publication date 2 February 2006

International Classifications

A61K 31/13 (2006.01) - Amines, e.g. amantadine

A61K 35/14 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Blood

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

5 June 2003 Complete Application Filed

19 June 2003 Application Open to Public Inspection

  Published as AU-B-2003204254

2 February 2006 Application Accepted

  Published as AU-B-2003204254

1 June 2006 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003204255-System and Method for Authorization of Location Services

2003204253-Intravenous catheter inserting device